
Ahmir Thompson Discloses Adult Autism, ADHD Testing
The Roots drummer said he sought autism and ADHD testing as an adult and urged others to consider getting assessed.
Across the United States, coverage here takes in research, education, diagnosis and advocacy. Reporting tracks clinical findings, legislative efforts and initiatives within the school system.

The Roots drummer said he sought autism and ADHD testing as an adult and urged others to consider getting assessed.
November 6, 2026
One Quarter of Adults Link Vaccines to AutismA survey of 30,288 U.S. adults found a quarter believe childhood vaccines and prenatal acetaminophen are tied to autism.
November 4, 2026
Study Links Autism Genes to Shared PathwayResearchers at Boston Children's Hospital identify the ZFX gene as a possible factor in autism's higher prevalence in males.
November 2, 2026
Tanner Smith Signs With WMEThe former Love on the Spectrum star has signed with the talent agency WME as Netflix renews the reality series for a fifth season.
November 1, 2026
Campbell Discusses Autism, Single Life on ShowActress Tisha Campbell returned to The Jennifer Hudson Show to discuss raising a son with autism and her experience of single life.
November 1, 2026
Psychiatrist Pushes Trump Derangement Syndrome DiagnosisDr. Carole Lieberman seeks formal recognition of the proposed condition, which the American Psychiatric Association does not recognize.
October 30, 2026
Study Links Caregiving to High-Functioning DepressionA new study identifies caregivers and parents as the group experiencing the highest levels of anhedonia and related depression symptoms.
October 28, 2026
Yamo Pharmaceuticals Tests New Autism Treatment DrugThe FDA-designated drug L1-79 aims to treat core autism symptoms following positive Phase 2 trial results.
October 27, 2026
Soar Autism Center Expands Pediatric Care AccessThe developmental pediatrics program served 600 children across four states since its 2025 launch.
October 26, 2026
Yamo Pharmaceuticals Advances Autism Drug to Phase 3The FDA granted Fast Track status to L1-79, a new medication targeting core neurological symptoms of autism.
October 23, 2026
Researchers Identify New ADHD SubtypeA study links a severe-combined ADHD subtype to distinct patterns of brain abnormality.
Day to day, that means studies on prevalence, new tools for early intervention, legislation aimed at access and inclusion, and developments in diagnostic practice. Reporting follows the conversation from national policy forums to the local environments where services are delivered. Advocacy organizations and researchers frequently highlight gaps between diagnostic recommendations and actual service availability. The focus on early screening and classroom support remains a consistent driver of public discussion.